PAK5 and hepatocellular carcinoma: Zhai et al. [30] found that miR-129 hampers tumor initiation and progression by targeting PAK5, whereas Zhao et al. [31] observed that miR-141 curbs hepatocellular carcinoma cell proliferation and invasion by downregulating TGFβR1.